Predictive diagnosis and genetic screening: Manipulation of fate?

Perspectives in Biology and Medicine

Volumn 41, Issue 2, 1998, Pages 282-289

  Henn, Wolfram ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; GENE MUTATION; GENETIC COUNSELING; GENETIC MANIPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; REVIEW;

EID: 0031932529     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.1998.0044     Document Type: Review

References (18)

1. FREUD, S. Die Traumdeutung. Leipzig/Vienna: Franz Deuticke, 1900.
2. MIKI, Y.; SWENSEN, J.; SHATTUCK-EIDENS, D.; et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
3. KINZLER, K. W.; NILBERT, M. C.; Su, L. K.; et al. Identification of FAP locus genes from chromosome 5q21. Science 253:551-665, 1991.
4. BENJAMIN, C. M.; ADAM, S.; WIGGINS, S.; et al. Proceed with care: Direct predictive testing for Huntington disease. Am. J. Hum. Genet. 55:606-617, 1994.
5. INTERNATIONAL HUNTINGTON ASSOCIATION, WORLD FEDERATION OF NEUROLOGY. Guidelines for the molecular genetic predictive test in Huntington's disease. J. Med. Genet. 31:555-559, 1994.
6. CODORI, A. M.; and BRANDT, J. Psychological costs and benefits of predictive testing for Huntington's disease. Am. J. Med. Genet. 54:174-184, 1994.
7. BIRMINGHAM, K. Insurers admit genetic discrimination (news). Nature Med. 3:710, 1997.
8. LAPHAM, E.V.; KOZMA, C.; and WEISS, J. O. Genetic discrimination: Perspectives of consumers. Science 274:621-623, 1997.
9. TAYLOR, C. A., and MYERS, R. H. Long-term impact of Huntington disease linkage testing. Am. J. Med. Genet. 70:365-370, 1997.
10. QUAID, K. A. Presymptomatic testing for Huntington disease in the United States. Am. J. Hum. Genet. 53:785-787, 1993.
11. KESSLER, S. Predictive testing for Huntington disease: A psychologist's view. Am. J. Med. Genet. 54:161-166, 1994.
12. WIGGINS, S.; WHYTE, P.; HUGGINS, M.; et al. The psychological consequences of predictive testing for Huntington's disease. N. Engl. J. Med. 327:1401-1405, 1992.
13. FODOR, S. P. A. Massively parallel genomics. Science 277:393-395, 1997.
14. KABACK, M.; LIM STEELE, J.; DABHOLKAR, D.; et al. Tay-Sachs disease - Carrier screening, prenatal diagnosis, and the molecular era: An international perspective. JAMA 270:2307-2315, 1993.
15. BURNETT, L.; PROOS, A. L.; CHESHER, D.; et al. The Tay-Sachs disease prevention program in Australia: Sydney pilot study. Med. J. Aust. 163:298-300, 1995.
16. SCHWARTZ, M.; BRANDT, N.J.; and SKOVBY, F. Screening for carriers of cystic fibrosis among pregnant women: A pilot study. Eur. J. Hum. Genet. 1 (3):239-244, 1993.
17. NATIONAL INSTITUTES OF HEALTH. Genetic testing for cystic fibrosis. NIH Consensus Statement Online 1997 April 14-16; 15(4): in press.
18. ALTAY, C.; YILGÖR, E.; BEKSAC, S.; and GÜRGEY, A. Premarital screening for hemoglobinopathies: A pilot study in Turkey. Hum. Hered. 46:112-114, 1996.